XML 44 R37.htm IDEA: XBRL DOCUMENT
v3.25.1

Net Loss Per Share (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2025
Earnings Per Share [Abstract] |
Summary of Weighted Average Number of Shares of Common Stock Outstanding |
|  | Three Months Ended March 31, |
|  | 2025 |  |  | 2024 |
Basic net loss per share: |  |  |  |  |  |
Numerator: |  |  |  |  |  |
Net loss |  | $ | (48,879,200 | ) |  | $ | (945,046 | )
Net loss attributable to common stockholders, basic and diluted |  | $ | (48,879,200 | ) |  | $ | (945,046 | )
Denominator: |  |  |  |  |  |
Basic shares: |  |  |  |  |  |
Weighted-average shares used to compute basic and diluted net loss per share |  |  | 25,436,398 |  |  |  | 5,836,882 |
Net loss per share attributable to common stockholders: |  |  |  |  |  |
Basic and diluted |  | $ | (1.92 | ) |  | $ | (0.16 | )
Summary of Calculation of Diluted Net Loss Per Share | The following potential common shares were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for the periods presented:
|  | Three Months Ended March 31, |
|  | 2025 |  |  | 2024 |
Convertible preferred stock |  |  | - |  |  |  | 10,204,880 |
Unvested restricted stock units |  |  | 638,211 |  |  |  | 1,426,111 |
SAFEs (1) |  |  | - |  |  |  | - |
Convertible notes (2) |  |  | 5,441,490 |  |  |  | - |
Investor warrants (3) |  |  | 15,099,378 |  |  |  | - |
Total anti-dilutive securities |  |  | 21,179,079 |  |  |  | 11,630,991 |
(1) The SAFEs were not included for purposes of calculating the number of diluted shares outstanding for the three months ended March 31, 2025 as the SAFEs were converted to common stock as of the Merger. The SAFEs were not included for purposes of calculating the number of diluted shares outstanding for the three months ended March 31, 2024 as the number of dilutive shares would be based on a conversion ratio associated with the pricing of the future financing or liquidation event, which was not determinable as of March 31, 2024. (2) The December 2024 Note contains a conversion feature that allows the Investor the option to convert the December 2024 Investor Note in exchange f or 1,739,130 shares of common stock. The March 2025 Investor Note contains a conversion feature that allows the Investor the option to convert in exchange for 3,702,360 shares of common stock. The effect of the incremental common shares issuable upon a conversion of these notes would be anti-dilutive based on Fold's average share price for three months ended March 31, 2025 and are therefore excluded from the loss per share calculation. (3) As of March 31, 2025, Fold had (1) 12,434,658 public warrants related to legacy FTAC Emerald at an exercise price of $11.50; (2) 869,565 Series A and 869,565 Series C Warrants outstanding related to the December 2024 Investor Note, at an exercise price of $12.50 and $11.50 per share, respectively; and (3) 925,590 Warrants outstanding related to the March 2025 Investor Note at an exercise price of $15.00. These warrants are considered anti-dilutive based on Fold's average share price for three months ended March 31, 2025 and are therefore excluded from the loss per share calculation.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration